treatment of celiac disease
Prevalence of Celiac disease in Turkish children with type 1 Diabetes Mellitus and their non-diabetic first-degree relatives pptx
Ngày tải lên :
05/03/2014, 12:20
... Magazzù G, Greco L. Duration of exposure to
gluten and risk for autoimmune disorders in patients with
celiac disease. SIGEP Study Group for Autoimmune Disor-
ders in Celiac Disease. Gastroenterology ... Prevalence of
celiac disease in a sample of Turkish children and adoles-
cents with type 1 diabetes mellitus. J Clin Gastroenterol
2006; 40: 655-7.
4. Tanure MG, Silva IN, Bahia M, et al. Prevalence of ... Development of ce-
liac disease- associated antibodies in offspring of parents
with type I diabetes. Diabetologia 2000; 43: 1005-11.
7. Jaeger C, Hatziagelaki E, Petzoldt R, et al. Comparative
analysis of...
- 5
- 453
- 0
Báo cáo Y học: The analysis of the fine specificity of celiac disease antibodies using tissue transglutaminase fragments pot
Ngày tải lên :
08/03/2014, 09:20
... Igs found in the serum of celiac
disease patients.
Keywords: autoimmunity; celiac disease; transglutaminase;
epitope mapping; phage display.
Celiac disease (CD) is a genetic disease strongly linked ... Greco, L. (1999) Duration of
exposure to gluten and risk for autoimmune disorders in
patients with celiac disease. SIGEP Study Group for
Autoimmune Disorders in Celiac Disease. Gastroenterology ... Schematic drawing of the cloning of 12 different tTG regions.
Reference numbers of the amino acid residues at the ends of the cloned
sequences are shown.
Ó FEBS 2002 Epitope mapping of anti-tTG Igs...
- 7
- 506
- 0
The Use of Selected Medicinal Herbs for Chemoprevention and Treatment of Cancer, Parkinson’s Disease, Heart Disease, and Depression
Ngày tải lên :
25/10/2013, 05:20
... decreased risk of aging, chronic disease, or cancer chemopre-
vention and treatment in the general population.
11.3 Parkinson’s Disease
Parkinson’s disease (also known as Parkinson disease or PD) ... μmol of TE (Trolox equivalents)·g
−1
of fresh weight (fwt), 131.2 mg·100 g
−1
of fwt, and 319.3 mg·100 g
−1
of fwt,
respectively. The organic culture also produced fruit with higher contents of
myricetin ... nor study subject can influ-
ence, or bias, the assessment of the effect of the treatment on disease outcome. RCT
study design features of particular importance include the following: an appropriate
and...
- 57
- 683
- 0
Tài liệu Báo cáo khoa học: Angiopoietin-like proteins: emerging targets for treatment of obesity and related metabolic diseases pptx
Ngày tải lên :
14/02/2014, 22:20
... emerging targets for treatment
of obesity and related metabolic diseases
Tsuyoshi Kadomatsu, Mitsuhisa Tabata and Yuichi Oike
Department of Molecular Genetics, Graduate School of Medical Sciences, ... with increased risk of cardiovascular disease, the leading cause of
death. Therefore, it is important to understand the molecular basis underly-
ing obesity and related metabolic diseases in order ... roles of ANGPTL2 and ANGPTL6 ⁄ AGF in obesity and
related metabolic diseases, and discuss the possibility that both could func-
tion as molecular targets for the prevention and treatment of obesity...
- 6
- 609
- 0
Tài liệu Báo cáo khoa học: Treatment of neutral glycosphingolipid lysosomal storage diseases via inhibition of the ABC drug transporter, MDR1 Cyclosporin A can lower serum and liver globotriaosyl ceramide levels in the Fabry mouse model doc
Ngày tải lên :
19/02/2014, 07:20
... Department of Medical Biophysics, University of Toronto, Canada
4 Department of Laboratory Medicine and Pathology, University of Toronto, Canada
5 Department of Biochemistry, University of Toronto, ... indicate the feasibility of using inhibition
of MDR1 as an approach to the treatment of Fabry
disease. Although the efficacy may not, as yet, be as
dramatic as ERT, inhibition of MDR1 may prove
most ... overnight with 2 mL of
chloroform ⁄ methanol (2 : 1 v ⁄ v) per 100 lL of plasma and
then partitioned against 1 ⁄ 5 volume of water. The lower
phase was dried under a stream of nitrogen gas and...
- 12
- 432
- 0
Hydroxyurea for the Treatment of Sickle Cell Disease docx
Ngày tải lên :
05/03/2014, 10:20
... effectiveness of hydroxyurea treatment of hematologic diseases, the toxicity
of hydroxyurea in the treatment of any disease, and the barriers to the treatment of sickle cell
disease with hydroxyurea ... long-term harms of its use in patients with sickle cell disease and other
diseases, and to discuss barriers to the use of hydroxyurea and other medications in the treatment
of sickle cell disease. ...
with Treatment for Patients with Sickle Cell Disease 61
Table 9. Summary of Barriers to Treatment of Sickle Cell Disease Reported by Patients
and Providers 63
Table 10. Results of Studies...
- 298
- 1.1K
- 0
Surgical Treatment of Parkinson’s Disease and Other Movement Disorders pot
Ngày tải lên :
05/03/2014, 23:20
... Collateralization of Striatofugal Neurons
and Co-localization of Dopamine Receptors
One of the important series of data that challenged the concept of segregated direct and indirect
striatofugal pathways ... different parts of MD mostly related to posterior regions of the frontal lobe, including
the frontal eye field areas of the premotor cortex (132). In rats, a lamellar organization of nigrofugal
neurons ... development of dyskinesias after transient inactivation of small areas
of the pallidum with the GABAergic agonist muscimol (178), over a wide range of injected concentra-
tions and volumes of the...
- 352
- 6.2K
- 2
Treatment of Tuberculosis - American Thoracic Society, CDC, and Infectious Diseases Society of America doc
Ngày tải lên :
06/03/2014, 04:20
... completion of 2 months of treatment, the continuation
phase of treatment should consist of isoniazid and rifampin daily or twice weekly for 4 months to complete
a total of 6 months of treatment. ... the strength of
treatment recommendations based on quality of evidence*
Strength of the recommendation
A. Preferred; should generally be offered
B. Alternative; acceptable to offer
C. Offer when ... Management
of Patients at Increased Risk of Relapse
The result of a sputum culture at the conclusion of the ini-
tial phase of treatment (2 months) has been shown to corre-
late with the likelihood of...
- 88
- 598
- 0
Báo cáo khoa học: The modulation of metal bio-availability as a therapeutic strategy for the treatment of Alzheimer’s disease pptx
Ngày tải lên :
07/03/2014, 10:20
... ameliorate several of
the dysfunctional events characteristic of Alzheimer’s disease. Metal-based
therapeutics have already provided promising results for the treatment of
Alzheimer’s disease, and ... therapeutic
strategy for the treatment of Alzheimer’s disease
Peter J. Crouch
1
, Anthony R. White
1
and Ashley I. Bush
2,3
1 Department of Pathology and Centre for Neuroscience, The University of Melbourne, ... development of effective therapeutic strategies
is hampered by a paucity of information on the biolo-
gical mechanisms underlying the disease. The severity
of AD relates to a multitude of age-related...
- 9
- 634
- 0
